Reason for request
Inclusion on the list of medicines approved for hospital use.
Clinical Benefit
| Substantial |
The actual benefit of this medicinal product is substantial. |
Clinical Added Value
| moderate |
BERINERT provides a moderate improvement in actual benefit (IAB III) in terms of effectiveness in managing episodes of hereditary angioedema in adults and children. |
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
RpaqfrVgUH2uZ0F4
